abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
91155: ROMA™ (Risk of Ovarian Malignancy Algorithm) Print View
ROMA Premenopausal CALC  < 1.31   
ROMA Postmenopausal CALC  < 2.77   
CA125 CMIA  < 35  U/mL 
HE4 EIA  < 151  pM 

PRIMARY
1 Serum 1 (0.5) mL   Refrigerated - 7 Day(s)/Room Temperature - 24 Hour(s)/Frozen - 28 Day(s)  
ALTERNATE
  Red Top   Refrigerated - 7 Day(s)/Frozen - 28 Day(s)/Room Temperature - 24 Hour(s)  

The Risk of Ovarian Malignancy Algorithm (ROMA(TM)) test is intended to aid in assessing the risk of ovarian cancer in women with a pelvic mass based on the patient's HE4 and CA125 levels, and their menopausal status. Women with ROMA(TM) levels above the cutoff have an increased risk of ovarian cancer. ROMA(TM) must be interpreted in conjunction with an independent clinical and radiological assessment.

Remove serum from the clot or red cells, respectively, as soon as
possible after clotting and separation.
Setup Schedule
Tuesday, Thursday

Reported (Analytical Time)
3 days

CPT Codes
86304,86305

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Reject Criteria: Gross and moderate hemolysis; lipemia; icteric Transport Temperature: Refrigerated Assay Category: FDA Approved/Modified






© 1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database